Invention Grant
- Patent Title: Treatment of post-bariatric hypoglycemia with exendin (9-39)
-
Application No.: US16813535Application Date: 2020-03-09
-
Publication No.: US10993991B2Publication Date: 2021-05-04
- Inventor: Tracey L. McLaughlin , Colleen M. Craig
- Applicant: The BOT of The Leland Stanford Junior University
- Applicant Address: US CA Palo Alto
- Assignee: The BOT of The Leland Stanford Junior University
- Current Assignee: The BOT of The Leland Stanford Junior University
- Current Assignee Address: US CA Palo Alto
- Agency: Kilpatrick, Townsend & Stockton LLC
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61P3/10 ; A61K38/22 ; A61K38/26 ; A61P3/08 ; A61K9/00 ; A61K45/06 ; A61K9/08 ; A61K9/10
Abstract:
Compositions and methods for treating hyperinsulinemic hypoglycemia, such as hyperinsulinemic hypoglycemia after bariatric surgery, are provided. In some embodiments, an effective amount of the glucagon-like peptide-1 receptor antagonist exendin(9-39) is subcutaneously administered twice per day.
Public/Granted literature
- US20200276271A1 TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA WITH EXENDIN (9-39) Public/Granted day:2020-09-03
Information query
IPC分类:
